James Altland serves as Executive at Onconova Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, James Altland has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Oct 10, 2013 involved exercising options for 5,000 shares valued at $30.0K.
James Altland currently holds 10,000 shares of Onconova Therapeutics, Inc. (ONTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James Altland has been a net neutral trader of ONTX stock. They have purchased $0 and sold $0 worth of shares.
James Altland's most recent insider trade was on Oct 10, 2013, when they sold 5,000 shares at $6.00 per share.
Get notified when new Form 4 filings are submitted
| 5,000 |
| $6.00 |
| Discretionary |